1 |
Feleszko, W., J. Jaworska, R. D. Rha, S. Steinhausen, A. Avagyan, A. Jaudszus, B. Ahrens, D. A. Groneberg, U. Wahn, and E. Hamelmann. 2007. Probiotic-induced suppression of allergic sensitization and airway inflammation is associated with an increase of T regulatory-dependent mechanisms in a murine model of asthma. Clin. Exp. Allergy 37:498-505.
DOI
ScienceOn
|
2 |
Leung, D. Y., M. Boguniewicz, M. D. Howell, I. Nomura, and Q. A. Hamid. 2004. New insights into atopic dermatitis. J. Clin. Invest. 113: 651-657.
DOI
|
3 |
Leung, D. Y., N. Jain, and H. L. Leo. 2003. New concepts in the pathogenesis of atopic dermatitis. Curr. Opin. Immunol.15: 634-638.
DOI
ScienceOn
|
4 |
Okada, H., C. Kuhn, H. Feillet, and J. F. Bach. 2010. The 'hygiene hypothesis' for autoimmune and allergic diseases: an update. Clin. Exp. Immunol. 160: 1-9.
|
5 |
Atherton, D. J. 2003. Topical corticosteroids in atopic dermatitis. BMJ 327: 942-943.
DOI
ScienceOn
|
6 |
Jia, W., H. Li, L. Zhao, and J. K. Nicholson. 2008. Gut microbiota: a potential new territory for drug targeting. Nat. Rev. Drug Discov. 7: 123-129.
DOI
ScienceOn
|
7 |
Bach, J. F. 2002. The effect of infections on susceptibility to autoimmune and allergic diseases. N. Engl. J. Med. 347:911-920.
DOI
ScienceOn
|
8 |
Maggi, E. 1998. The TH1/TH2 paradigm in allergy. Immunotechnology 3: 233-244.
DOI
ScienceOn
|
9 |
Rautava, S., O. Ruuskanen, A. Ouwehand, S. Salminen, and E. Isolauri. 2004. The hygiene hypothesis of atopic disease-- an extended version. J. Pediatr. Gastroenterol. Nutr. 38:378-388.
DOI
ScienceOn
|
10 |
Shreiner, A., G. B. Huffnagle, and M. C. Noverr. 2008. The "Microflora Hypothesis" of Allergic Disease. In GI Microbiota and Regulation of the Immune System. Springer, New York, USA. pp.113-134
|
11 |
Turnbaugh, P. J., R. E. Ley, M. Hamady, C. M. Fraser-Liggett, R. Knight, and J. I. Gordon. 2007. The human microbiome project. Nature 449: 804-810.
DOI
ScienceOn
|
12 |
Sheil, B., J. McCarthy, L. O'Mahony, M. W. Bennett, P. Ryan, J. J. Fitzgibbon, B. Kiely, J. K. Collins, and F. Shanahan. 2004. Is the mucosal route of administration essential for probiotic function? Subcutaneous administration is associated with attenuation of murine colitis and arthritis. Gut 53: 694-700.
DOI
ScienceOn
|
13 |
Madsen, K. L., J. S. Doyle, L. D. Jewell, M. M. Tavernini, and R. N. Fedorak. 1999. Lactobacillus species prevents colitis in interleukin 10 gene-deficient mice. Gastroenterology 116: 1107-1114.
DOI
ScienceOn
|
14 |
Schultz, M., C. Veltkamp, L. A. Dieleman, W. B. Grenther, P. B. Wyrick, S. L. Tonkonogy, and R. B. Sartor. 2002. Lactobacillus plantarum 299V in the treatment and prevention of spontaneous colitis in interleukin-10-deficient mice. Inflamm. Bowel Dis. 8: 71-80.
DOI
ScienceOn
|
15 |
Khoruts, A., and M. J. Sadowsky. 2011. Therapeutic transplantation of the distal gut microbiota. Mucosal Immunol. 4: 4-7.
DOI
ScienceOn
|
16 |
Delzenne, N. M., A. M. Neyrinck, F. Bäckhed, and P. D. Cani. 2011. Targeting gut microbiota in obesity: effects of prebiotics and probiotics. Nat. Rev. Endocrinol. 7: 639-646.
DOI
ScienceOn
|
17 |
Favier, C., C. Neut, C. Mizon, A. Cortot, J. F. Colombel, and J. Mizon. 1997. Fecal beta-D-galactosidase production and Bifidobacteria are decreased in Crohn's disease. Dig. Dis. Sci.42: 817-822.
DOI
ScienceOn
|
18 |
Won, T. J., B. Kim, Y. T. Lim, D. S. Song, S. Y. Park, E. S. Park, D. I. Lee, and K. W. Hwang. 2011. Oral administration of Lactobacillus strains from Kimchi inhibits atopic dermatitis in NC/Nga mice. J. Appl. Microbiol. 110: 1195-1202.
DOI
ScienceOn
|
19 |
Bouma, G., and W. Strober. 2003. The immunological and genetic basis of inflammatory bowel disease. Nat. Rev. Immunol. 3: 521-533.
DOI
ScienceOn
|
20 |
Swidsinski, A., A. Ladhoff, A. Pernthaler, S. Swidsinski, V. Loening-Baucke, M. Ortner, J. Weber, U. Hoffmann, S. Schreiber, M. Dietel, and H. Lochs. 2002. Mucosal flora in inflammatory bowel disease. Gastroenterology 122: 44-54.
DOI
ScienceOn
|
21 |
Gupta, P., H. Andrew, B. S. Kirschner, and S. Guandalini. 2000. Is lactobacillus GG helpful in children with Crohn's disease? Results of a preliminary, open-label study. J. Pediatr. Gastroenterol. Nutr. 31: 453-457.
DOI
ScienceOn
|
22 |
Kruis, W., P. Fric, and M. S. Stolte. 2001. Maintenance of remission in ulcerative colitis is equally effective with Escherichia coli Nissle 1917 and with standard mesalamine. Gastroenterology 120(5 Suppl 1): A127.
DOI
|
23 |
Malchow, H. A. 1997. Crohn's disease and Escherichia coli. A new approach in therapy to maintain remission of colonic Crohn's disease? J. Clin. Gastroenterol. 25: 653-658.
DOI
ScienceOn
|
24 |
Gionchetti, P., F. Rizzello, A. Venturi, P. Brigidi, D. Matteuzzi, G. Bazzocchi, G. Poggioli, M. Miglioli, and M. Campieri. 2000. Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo- controlled trial. Gastroenterology 119: 305-309.
DOI
ScienceOn
|
25 |
Venturi, A., P. Gionchetti, F. Rizzello, R. Johansson, E. Zucconi, P. Brigidi, D. Matteuzzi, and M. Campieri. 1999. Impact on the composition of the faecal flora by a new probiotic preparation: preliminary data on maintenance treatment of patients with ulcerative colitis. Aliment. Pharmacol. Ther.13: 1103-1108.
DOI
ScienceOn
|
26 |
Kopp, M. V., I. Hennemuth, A. Heinzmann, and R. Urbanek. 2008. Randomized, double-blind, placebo-controlled trial of probiotics forprimary prevention: no clinical effects of Lactobacillus GG supplementation. Pediatrics 121: e850-856.
DOI
ScienceOn
|
27 |
O'Mahony, L., M. Feeney, S. O'Halloran, L. Murphy, B. Kiely, J. Fitzgibbon, G. Lee, G. O'Sullivan, F. Shanahan, and J. K. Collins. 2001. Probiotic impact on microbial flora, inflammation and tumour development in IL-10 knockout mice. Aliment. Pharmacol. Ther. 15: 1219-1225.
DOI
ScienceOn
|
28 |
Sheil, B., J. MacSharry, L. O'Callaghan, A. O'Riordan, A. Waters, J, Morgan, J. K. Collins, L. O'Mahony, and F. Shanahan. 2006. Role of interleukin (IL-10) in probioticmediated immune modulation: an assessment in wild-type and IL-10 knock-out mice. Clin. Exp. Immunol. 144: 273-280.
DOI
ScienceOn
|
29 |
Soh, S. E., M. Aw, I. Gerez, Y. S. Chong, M. Rauff, Y. P. Ng, H. B. Wong, N. Pai, B. W. Lee, and L. P. Shek. 2009. Probiotic supplementation in the first 6 months of life in at risk Asian infants--effects on eczema and atopic sensitization at the age of 1 year. Clin. Exp. Allergy 39: 571-578.
DOI
ScienceOn
|
30 |
Weston, S., A. Halbert, P. Richmond, and S. L. Prescott. 2005. Effects of probiotics on atopic dermatitis: a randomised controlled trial. Arch. Dis. Child. 90: 892-897.
DOI
ScienceOn
|
31 |
Viljanen, M., E. Savilahti, T. Haahtela, K. Juntunen-Backman, R. Korpela, T. Poussa, T. Tuure, and M. Kuitunen. 2005. Probiotics in the treatment of atopic eczema/dermatitis syndrome in infants: a double-blind placebo-controlled trial. Allergy 60: 494-500.
DOI
ScienceOn
|
32 |
Sistek, D., R. Kelly, K. Wickens, T. Stanley, P. Fitzharris, and J. Crane. 2006. Is the effect of probiotics on atopic dermatitis confined to food sensitized children? Clin. Exp. Allergy36 :629-633.
DOI
ScienceOn
|
33 |
Fölster-Holst, R., F. Müller, N. Schnopp, D. Abeck, I. Kreiselmaier, T. Lenz, von U. Rüden, J. Schrezenmeir, E. Christophers, and M. Weichenthal. 2006. Prospective, randomized controlled trial on Lactobacillus rhamnosus in infants with moderate to severe atopic dermatitis. Br. J. Dermatol. 155: 1256-1261.
DOI
ScienceOn
|
34 |
Chen, Y. S., R. L. Jan, Y. L. Lin, H. H. Chen, and J. Y. Wang. 2010. Randomized placebo-controlled trial of lactobacillus on asthmatic children with allergic rhinitis. Pediatr. Pulmonol. 45: 1111-1120.
DOI
ScienceOn
|
35 |
Vestergaard, C., N. Kirstejn, B. Gesser, J. T. Mortensen, K. Matsushima, and C. G. Larsen. 2001. IL-10 augments the IFN-gamma and TNF-alpha induced TARC production in HaCaT cells: a possible mechanism in the inflammatory reaction of atopic dermatitis. J. Dermatol. Sci. 26: 46-54.
DOI
ScienceOn
|
36 |
Sawada, J., H. Morita, A. Tanaka, S. Salminen, F. He, and H. Matsuda. 2007. Ingestion of heat-treated Lactobacillus rhamnosus GG prevents development of atopic dermatitis in NC/Nga mice. Clin. Exp. Allergy 37: 296-303.
DOI
ScienceOn
|
37 |
Tanaka, A., K. Jung, J. Benyacoub, G. Prioult, N. Okamoto, K. Ohmori, S. Blum, A. Mercenier, and H. Matsuda. 2009. Oral supplementation with Lactobacillus rhamnosus CGMCC1.3724 prevents development of atopic dermatitis in NC/NgaTnd mice possibly by modulating local production of IFN-gamma. Exp. Dermatol. 18: 1022-1027.
DOI
ScienceOn
|
38 |
Homey, B., M. Steinhoff, T. Ruzicka, and D. Y. Leung. 2006. Cytokines and chemokines orchestrate atopic skin inflammation. J. Allergy Clin. Immunol. 118: 178-189.
DOI
ScienceOn
|
39 |
Konur, A., U. Schulz, G. Eissner, R. Andreesen, and E. Holler. 2005. Interferon (IFN)-gamma is a main mediator of keratinocyte (HaCaT) apoptosis and contributes to autocrine IFN-gamma and tumour necrosis factor-alpha production. Br. J. Dermatol. 152: 1134-1142.
DOI
ScienceOn
|
40 |
Pivarcsi, A., and B. Homey. Chemokine networks in atopic dermatitis: traffic signals of disease. Curr. Allergy Asthma Rep. 5: 284-290.
|
41 |
Trautmann, A., M. Akdis, D. Kleemann, F. Altznauer, H. U. Simon, T. Graeve, M. Noll, E. B. Bröcker, K. Blaser, and C. A. Akdis. 2000. T cell-mediated Fas-induced keratinocyte apoptosis plays a key pathogenetic role in eczematous dermatitis. J. Clin. Invest. 106: 25-35.
DOI
ScienceOn
|
42 |
Kalliomäki, M., S. Salminen, H. Arvilommi, P. Kero, P. Koskinen, and E. Isolauri. 2001. Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial. Lancet. 357: 1076-1079.
DOI
ScienceOn
|
43 |
Abrahamsson, T. R., T. Jakobsson, M. F. Bottcher, M. Fredrikson, M. C. Jenmalm, B. Bjorksten, and G. Oldaeus. 2007. Probiotics in prevention of IgE-associated eczema: a double-blind, randomized, placebo-controlled trial. J. Allergy Clin. Immunol. 119: 1174-1180.
DOI
ScienceOn
|
44 |
Kwon, H. K., C. G. Lee, J. S. So, C. S. Chae, J. S. Hwang, A. Sahoo, J. H. Nam, J. H. Rhee, K. C. Hwang, and S. H. Im. 2012. Generation of regulatory dendritic cells and T cells by probiotics administration suppresses immune disorders. Proc. Natl. Acad. Sci. U.S.A. 107: 2159-2164.
|
45 |
Wickens, K., P. N. Black, T. V. Stanley, E. Mitchell, P. Fitzharris, G. W. Tannock, G. Purdie, J. Crane Probiotic Study Group. 2008. A differential effect of 2 probiotics in the prevention of eczema and atopy: a double-blind, randomized, placebo-controlled trial. J. Allergy Clin. Immunol. 122: 788-794.
DOI
ScienceOn
|
46 |
Smits, H. H., A. Engering, D. van der Kleij, E. C. de Jong, K. Schipper, T. M. van Capel, B. A. Zaat, M. Yazdanbakhsh, E. A. Wierenga, Y. van Kooyk, and M. L. Kapsenberg. 2005. Selective probiotic bacteria induce IL-10-producing regulatory T cells in vitro by modulating dendritic cell function through dendritic cell-specific intercellular adhesion molecule 3-grabbing nonintegrin. J. Allergy Clin. Immunol. 115: 1260-1267.
DOI
ScienceOn
|
47 |
Ueno, N., M. Fujiya, S. Segawa, T. Nata, K. Moriichi, H. Tanabe, Y. Mizukami, N. Kobayashi, K. Ito, and Y. Kohgo. 2011. Heat-killed body of lactobacillus brevis SBC8803 ameliorates intestinal injury in a murine model of colitis by enhancing the intestinal barrier function. Inflamm. Bowel Dis. 17: 2235-2250.
DOI
ScienceOn
|
48 |
Winkler, P., D. Ghadimi, J. Schrezenmeir, and J. P. Kraehenbuhl. 2007. Molecular and cellular basis of microflora-host interactions. J. Nutr. 137(3 Suppl 2): 756S-772S.
DOI
|
49 |
Fink, L. N., L. H. Zeuthen, G. Ferlazzo, and H. Frøkiaer. 2007. Human antigen-presenting cells respond differently to gut-derived probiotic bacteria but mediate similar strain-dependent NK and T cell activation. FEMS Immunol. Med. Microbiol. 51: 535-546.
DOI
|
50 |
Young, S. L., M. A. Simon, M. A. Baird, G. W. Tannock, R. Bibiloni, K. Spencely, J. M. Lane, P. Fitzharris, J. Crane, I. Town, E. Addo-Yobo, C. S. Murray, and A. Woodcock. 2004. Bifidobacterial species differentially affect expression of cell surface markers and cytokines of dendritic cells harvested from cord blood. Clin. Diagn. Lab. Immunol. 11: 686-690.
|
51 |
Zeuthen, L. H., H. R. Christensen, and H. Frøkiaer. 2006. Lactic acid bacteria inducing a weak interleukin-12 and tumor necrosis factor alpha response in human dendritic cells inhibit strongly stimulating lactic acid bacteria but act synergistically with gram-negative bacteria. Clin. Vaccine Immunol. 13: 365-375.
DOI
ScienceOn
|
52 |
Lai, Y., A. Di Nardo, T. Nakatsuji, A. Leichtle, Y. Yang, A. L. Cogen, Z. R. Wu, L. V. Hooper, R. R. Schmidt, S. von Aulock, K. A. Radek, C. M. Huang, A. F. Ryan, and R. L. Gallo. 2009. Commensal bacteria regulate Toll-like receptor 3-dependent inflammation after skin injury. Nat. Med. 15: 1377-1382.
DOI
ScienceOn
|
53 |
Grice, E. A., H. H. Kong, S. Conlan, C. B. Deming, J. Davis, A. C. Young NISC Comparative Sequencing Program, G. G. Bouffard, R. W. Blakesley, P. R. Murray, E. D. Green, M. L. Turner, and J. A. Segre. 2009. Topographical and temporal diversity of the human skin microbiome. Science 324: 1190-1192.
DOI
ScienceOn
|
54 |
Gallo, R. L., and T. Nakatsuji. 2011. Microbial symbiosis with the innate immune defense system of the skin. J. Invest. Dermatol. 131: 1974-1980.
DOI
ScienceOn
|
55 |
Kong, H. H., J. Oh, C. Deming, S. Conlan, E. A. Grice, M. A. Beatson, E. Nomicos, E. C. Polley, H. D. Komarow, NISC Comparative Sequence Program, P. R. Murray, M. L. Turner, and J. A. Segre. 2012. Temporal shifts in the skin microbiome associated with disease flares and treatment in children with atopic dermatitis. Genome Res. 22: 850-859.
DOI
ScienceOn
|
56 |
Naik, S., N. Bouladoux, C. Wilhelm, M. J. Molloy, R. Salcedo, W. Kastenmuller, C. Deming, M. Quinones, L. Koo, S. Conlan, S. Spencer, J. A. Hall, A. Dzutsev, H. Kong, D. J. Campbell, G. Trinchieri, J. A. Segre, and Y. Belkaid. 2012. Compartmentalized control of skin immunity by resident commensals. Science 337: 1115-1119.
DOI
ScienceOn
|
57 |
Ouwehand, A. C., M. Derrien, W. de Vos, K. Tiihonen, and N. Rautonen. 2005. Prebiotics and other microbial substrates for gut functionality. Curr. Opin. Biotechnol. 16: 212-217.
DOI
ScienceOn
|
58 |
Adlerberth, I., M. Cerquetti, I. Poilane, A. Wold, and A. Collignon. 2000. Mechanisms of Colonisation and Colonisation Resistance of the Digestive Tract Part 1: Bacteria/host Interactions. Microb. Ecol. Health Dis. 2: 223-239.
|
59 |
Fang, H., T. Elina, A. Heikki, and S. Seppo. 2000. Modulation of humoral immune response through probiotic intake. FEMS Immunol. Med. Microbiol. 29: 47-52.
DOI
ScienceOn
|
60 |
Gill, H. S., K. J. Rutherfurd, M. L. Cross, and P. K. Gopal. 2001. Enhancement of immunity in the elderly by dietary supplementation with the probiotic Bifidobacterium lactis HN019. Am. J. Clin. Nutr. 74: 833-839.
DOI
|
61 |
Giongo, A., K. A. Gano, D. B. Crabb, N. Mukherjee, L. L. Novelo, G. Casella, J. C. Drew, J. Ilonen, M. Knip, H. Hyöty, R. Veijola, T. Simell, O. Simell, J. Neu, C. H. Wasserfall, D. Schatz, M. A. Atkinson, and E. W. Triplett. 2011. Toward defining the autoimmune microbiome for type 1 diabetes. ISME J. 5:82-91.
DOI
|
62 |
Turnbaugh, P. J., R. E. Ley, M. A. Mahowald, V. Magrini, E. R. Mardis, and J. I. Gordon. 2006. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 444: 1027-1031.
DOI
ScienceOn
|
63 |
Ley, R. E., P. J. Turnbaugh, S. Klein, and J. I. Gordon. 2006. Microbial ecology: human gut microbes associated with obesity. Nature 444: 1022-1023.
DOI
ScienceOn
|
64 |
Million, M., M. Maraninchi, M. Henry, F. Armougom, H. Richet, P. Carrieri, R. Valero, D. Raccah, B. Vialettes, and D. Raoult. 2012. Obesity-associated gut microbiota is enriched in Lactobacillus reuteri and depleted in Bifidobacterium animalis and Methanobrevibacter smithii. Int. J. Obes. (Lond). 36: 817-825.
DOI
ScienceOn
|
65 |
Ogden, N. S., and L. Bielory. 2005. Probiotics: a complementary approach in the treatment and prevention of pediatric atopic disease. Curr. Opin. Allergy Clin. Immunol. 5: 179-184.
DOI
ScienceOn
|
66 |
Guarner, F., and J. R. Malagelada. 2003. Gut flora in health and disease. Lancet. 361: 512-519.
DOI
|
67 |
Artis, D. 2008. Epithelial-cell recognition ofcommensal bacteria and maintenance of immune homeostasis in the gut. Nat. Rev. Immunol. 8: 411-420.
DOI
ScienceOn
|
68 |
Macdonald, T. T., and G, Monteleone. 2005. Immunity, inflammation, and allergy in the gut. Science 307: 1920-1925.
DOI
ScienceOn
|
69 |
Kelly, D., S. Conway, and R. Aminov. 2005. Commensal gut bacteria: mechanisms of immune modulation. Trends Immunol. 26: 326-333.
DOI
ScienceOn
|
70 |
Coombes, J. L., and F. Powrie. 2008. Dendritic cells in intestinal immune regulation. Nat. Rev. Immunol. 8: 435-446.
DOI
ScienceOn
|
71 |
Rescigno, M., M. Urbano, B. Valzasina, M. Francolini, G. Rotta, R. Bonasio, F. Granucci, J. P. Kraehenbuhl, and P. Ricciardi-Castagnoli. 2001. Dendritic cells express tight junction proteins and penetrate gut epithelial monolayers to sample bacteria. Nat. Immunol. 2: 361-367.
DOI
ScienceOn
|
72 |
Ostman, S., C. Rask, A. E. Wold, S. Hultkrantz, and E. Telemo. 2006. Impaired regulatory T cell function in germ-free mice. Eur. J. Immunol. 36: 2336-2346.
DOI
ScienceOn
|
73 |
Mowat, A. M. 2003. Anatomical basis of tolerance and immunity to intestinal antigens. Nat. Rev. Immunol. 3: 331-341.
DOI
ScienceOn
|
74 |
O'Hara, A. M., and F. Shanahan. 2006. The gut flora as a forgotten organ. EMBO Rep. 7: 688-693.
DOI
ScienceOn
|
75 |
Sudo, N., S. Sawamura, K. Tanaka, Y. Aiba, C. Kubo, and Y. Koga. 1997. The requirement of intestinal bacterial flora for the development of an IgE production system fully susceptible to oral tolerance induction. J. Immunol. 159: 1739-1745.
|
76 |
Kong, H. H. 2011. Skin microbiome: genomics-based insights into the diversity and role of skin microbes. Trends Mol. Med. 17: 320-328.
DOI
ScienceOn
|
77 |
Human Microbiome Jumpstart Reference Strains Consortium, K. E. Nelson, G. M. Weinstock, S. K. Highlander, K. C. Worley, H. H. Creasy, J. R. Wortman, D. B. Rusch, M. Mitreva, E. Sodergren, A. T. Chinwalla, M. Feldgarden, D. Gevers, B. J. Haas, R. Madupu, D. V. Ward, B. W. Birren, R. A. Gibbs, B. Methe, J. F. Petrosino, R. L. Strausberg, G. G. Sutton, O. R. White, R. K. Wilson, S. Durkin, M. G. Giglio, S. Gujja, C. Howarth, C. D. Kodira, N. Kyrpides, T. Mehta, D. M. Muzny, M. Pearson, K. Pepin, A. Pati, X. Qin, C. Yandava, Q. Zeng, L. Zhang, A. M. Berlin, L. Chen, T. A. Hepburn, J. Johnson, J. McCorrison, J. Miller, P. Minx, C. Nusbaum, C. Russ, S. M. Sykes, C. M. Tomlinson, S. Young, W. C. Warren, J. Badger, J. Crabtree, V. M. Markowitz, J. Orvis, A. Cree, S. Ferriera, L. L. Fulton, R. S. Fulton, M. Gillis, L. D. Hemphill, V. Joshi, C. Kovar, M. Torralba, K. A. Wetterstrand, A. Abouellleil, A. M. Wollam, C. J. Buhay, Y. Ding, S. Dugan, M. G. FitzGerald, M. Holder, J. Hostetler, S. W. Clifton, E. Allen-Vercoe, A. M. Earl, C. N. Farmer, K. Liolios, M. G. Surette, Q. Xu, C. Pohl, K. Wilczek-Boney, and D. Zhu. 2010. A catalog of reference genomes from the human microbiome. Science 328: 994-999.
DOI
ScienceOn
|
78 |
Tlaskalova-Hogenova, H., R. Stepankova, H. Kozakova, T. Hudcovic, L. Vannucci, L. Tuckova, P. Rossmann, T. Hrncir, M. Kverka, Z. Zakostelska, K. Klimesova, J. Pribylova, J. Bartova, D. Sanchez, P. Fundova, D. Borovska, D. Srutkova, Z. Zidek, M. Schwarzer, P. Drastich, and D. P. Funda. 2011. The role of gut microbiota (commensal bacteria) and the mucosal barrier in the pathogenesis of inflammatory and autoimmune diseases and cancer: contribution of germ-free and gnotobiotic animal models of human diseases. Cell. Mol. Immunol. 8: 110-120.
DOI
ScienceOn
|
79 |
Cho, I., and M. J. Blaser. 2012. The human microbiome: at the interface of health and disease. Nat. Rev. Genet. 13: 260-270.
DOI
|
80 |
Human Microbiome Project Consortium. 2012. A framework for human microbiome research. Nature 486: 215-221.
DOI
ScienceOn
|
81 |
Flohr, C., D. Pascoe, and H. C. Williams. 2005. Atopic dermatitis and the 'hygiene hypothesis': too clean to be true? Br. J. Dermatol. 152: 202-216.
DOI
ScienceOn
|
82 |
Gibbs, S., H. Surridge, R. Adamson, B. Cohen, G. Bentham, and R. Reading. 2004. Atopic dermatitis and the hygiene hypothesis: a case-control study. Int. J. Epidemiol. 33: 199-207.
DOI
ScienceOn
|
83 |
Kalliomaki, M., P. Kirjavainen, E. Eerola, P. Kero, S. Salminen, and E. Isolauri. 2001. Distinct patterns of neonatal gut microflora in infants in whom atopy was and was not developing. J. Allergy Clin. Immunol. 107: 129-134.
DOI
ScienceOn
|
84 |
Penders, J., C. Thijs, P. A. van den Brandt, I. Kummeling, B. Snijders, F. Stelma, H. Adams, R. van Ree, and E. E. Stobberingh. 2007. Gut microbiota composition and development of atopic manifestations in infancy: the KOALA Birth Cohort Study. Gut 56: 661-667.
DOI
ScienceOn
|
85 |
Kendler, M., W. Uter, A. Rueffer, R. Shimshoni, and E. Jecht. 2006. Comparison of fecal microflora in children with atopic eczema/dermatitis syndrome according to IgE sensitization to food. Pediatr. Allergy Immunol. 17: 141-147.
DOI
ScienceOn
|
86 |
Ouwehand, A. C. 2007. Antiallergic effects of probiotics. J. Nutr. 137(3 Suppl 2): 794S-797S.
DOI
|
87 |
Miraglia del Giudice, M. Jr., M. G. De Luca, and C. Capristo. 2002. Probiotics and atopic dermatitis. A new strategy in atopic dermatitis. Dig. Liver Dis. 34 Suppl 2: S68-71.
DOI
|
88 |
Sheil, B., F. Shanahan, and L. O'Mahony. 2007. Probiotic effects on inflammatory bowel disease. J. Nutr. 137(3 Suppl2): 819S-824S.
DOI
|
89 |
Sanders, M. E. 2008. Probiotics: definition, sources, selection, and uses. Clin. Infect. Dis. 46 Suppl 2: S58-61.
DOI
|